Wells Fargo
RXII

Wells Fargo’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Wells Fargo’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-185,200
Closed -$7K – 6707
2016
Q3 		$7K Buy
185,200
+15,200
+9% +$575 ﹤0.01% 5853
2016
Q2 		$32K Buy
170,000
+40,500
+31% +$7.62K ﹤0.01% 5356
2016
Q1 		$67K Buy
+129,500
New +$67K ﹤0.01% 5103

Wells Fargo's RXII Position: Q4 2016 in Review

Wells Fargo sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 177,335 shares — an estimated $62K sold.

Wells Fargo first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $388K in Q2 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Wells Fargo reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Wells Fargo sold 177,335 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $62K.
  • Wells Fargo first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
  • Wells Fargo's GALENA BIOPHARMA INC COM position peaked at $388K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Wells Fargo's 13F filing for Q4 2016, filed 1 Feb 2017.